| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Chief Executive Officer
2 companies
O'Connor Daniel J. serves as a Director, 10% Owner at ZVSA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 5 sells. Those positions are worth an estimated $4.0M at current prices.
The biggest single holding is ADXS (~$4.0M) as Chief Executive Officer. The recent filings there lean toward selling, a net 42,094 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2016 | ADXS Ayala Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,240 | $8.32 | $68,556.80 | -2.7% | |
| May 2, 2016 | ADXS Ayala Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,237 | $7.51 | $61,859.87 | -2.6% | |
| Jan 29, 2016 | ADXS Ayala Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,818 | $6.88 | $60,667.84 | -2.7% | |
| Oct 30, 2015 | ADXS Ayala Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,350 | $12.26 | $102,371.00 | -2.5% | |
| Jul 31, 2015 | ADXS Ayala Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 8,449 | $15.44 | $130,452.56 | -2.4% |